Efficacy and safety of hyaluronidase-facilitated subcutaneous immunoglobulin 10% in US pediatric patients with primary immunodeficiency disease

Authors
Category Primary study
JournalClinical Immunology
Year 2023
This article has no abstract
Epistemonikos ID: 7a77886a53a62b1182aafc40d78b09094171f376
First added on: Feb 15, 2025